Barrington Research Reiterates “Outperform” Rating for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “outperform” rating reiterated by investment analysts at Barrington Research in a report issued on Friday,Benzinga reports. They currently have a $103.00 target price on the stock. Barrington Research’s target price would suggest a potential upside of 21.06% from the company’s current price.

Several other equities analysts also recently weighed in on the stock. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. Finally, JPMorgan Chase & Co. lowered their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Four investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.

U.S. Physical Therapy Stock Down 1.6%

NYSE USPH opened at $85.08 on Friday. The business has a fifty day moving average price of $83.30 and a 200 day moving average price of $82.55. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.20 and a current ratio of 1.20. The company has a market cap of $1.29 billion, a P/E ratio of 35.75, a P/E/G ratio of 3.51 and a beta of 1.30. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $93.50.

Institutional Trading of U.S. Physical Therapy

Several institutional investors have recently made changes to their positions in the company. Envestnet Asset Management Inc. lifted its stake in shares of U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock valued at $27,070,000 after purchasing an additional 29,671 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in shares of U.S. Physical Therapy during the 3rd quarter worth about $845,000. Geode Capital Management LLC raised its holdings in U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock valued at $27,602,000 after buying an additional 4,306 shares during the period. Bank of New York Mellon Corp lifted its position in U.S. Physical Therapy by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock valued at $10,288,000 after buying an additional 6,190 shares during the last quarter. Finally, CenterBook Partners LP lifted its position in U.S. Physical Therapy by 189.0% in the second quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock valued at $3,676,000 after buying an additional 30,746 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.